
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66080
Endocrinology/Diabetes/Metabolism
Genetics
Pediatrics
A Novel Steroidogenic Acute Regulatory Protein (StAR) Mutation Causing Adrenal Insufficiency in a Neonate: A Case Report of a Rare Medical Condition
Muacevic Alexander
Adler John R
Rawat Aditi 1
Karotkar Sagar 2
Lakra Mahaveer 2
Reddy Ravi 1
Meshram Revatdhamma 2
Taksande Amar 2
1 Department of Neonatology, Datta Meghe Institute of Higher Education and Research, Wardha, IND
2 Department of Pediatrics, Datta Meghe Institute of Higher Education and Research, Wardha, IND
Aditi Rawat aditirawat0691@gmail.com
3 8 2024
8 2024
16 8 e660806 7 2024
3 8 2024
Copyright © 2024, Rawat et al.
2024
Rawat et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/275035-a-novel-steroidogenic-acute-regulatory-protein-star-mutation-causing-adrenal-insufficiency-in-a-neonate-a-case-report-of-a-rare-medical-condition
Congenital lipoid adrenal hyperplasia is a very rare and severe cause of adrenal insufficiency. It occurs due to a mutation of the steroidogenic acute regulatory protein (StAR), disrupting adrenal steroid biosynthesis. Here, we report a case of a three-week-old female infant with vomiting, failure to thrive, electrolyte imbalance, and generalized hyperpigmentation. The hormonal assay and genetic diagnosis confirmed a mutation in the StAR protein, leading to adrenal insufficiency. Appropriate replacement therapy resulted in the resolution of clinical and biochemical abnormalities. This case is being reported for its rare etiology and diagnostic clues. It can guide clinicians to keep adrenal insufficiency as a differential diagnosis in a neonate presenting with hyperpigmentation and electrolyte disturbance to save lives.

hyperpigmentation
hyperkalemia
hyponatremia
neonate
star mutation
lipoid congenital adrenal hyperplasia
==== Body
pmcIntroduction

Congenital lipoid adrenal hyperplasia (CLAH) is an extremely rare subtype of congenital adrenal hyperplasia (CAH). The first step in the adrenal and gonadal steroid synthetic pathway is blocked, leading to the nonconversion of cholesterol to pregnenolone [1]. The incidence of this genetic disorder is 1 in 250,000 to 1 in 300,000 newborns, and it is more frequent in the Japanese and Korean populations [2]. There is a progressive accumulation of cholesterol in the adrenal gland and the deficient synthesis of glucocorticoids, mineralocorticoids, and androgens culminating in hypoglycemia, electrolyte imbalance, abnormal male external genitalia, and adrenal hypertrophy in the neonate [3]. Here, we present a case of a three-week-old neonate who presented with symptoms of vomiting, hyponatremia, and hyperkalemia due to this rare genetic disorder.

Case presentation

A female infant with a birth weight of 3 kg was born to a primigravida mother at 37 weeks of gestational age, with no antenatal or postnatal complications. On day 22, the baby was admitted to our hospital with lethargy and vomiting. On examination, the baby was hyporesponsive with a heart rate of 145/minute, respiratory rate of 55/minute, and well palpable pulses. Random blood sugar was 28 mg/dL, for which a bolus of 10% dextrose at 2 mL/kg was given. IV fluids with a glucose infusion rate (GIR) of 6 mg/kg/minute were started. The skin had generalized dark pigmentation, which parents complained was progressively increasing, as skin color was fair at birth, as shown in Figure 1.

Figure 1 Generalized hyperpigmentation of skin

Normal external female genitalia was present with no palpable abdominal or inguinal mass, as shown in Figure 2.

Figure 2 Normal female external genitalia

There was no family history of similar conditions, any endocrine diseases, or neonatal deaths. The infant had failed to thrive as well, with 23% weight loss since birth. Initial investigation ruled out sepsis and meningitis, but hyponatremia and hyperkalemia with acute kidney injury were noted, as shown in Table 1.

Table 1 Electrolytes and renal function test reports

Normal reference range in neonates: serum sodium: 135-145 mEq/L; serum potassium: 3.5-5.2 mEq/L; serum urea: 5-15 mg/dL; serum creatinine: 0.54-1 mg/dL

Day of life	Serum sodium (mEq/L)	Serum potassium (mEq/L)	Serum urea (mg/dL)	Serum creatinine (mg/dL)	
Day 22	Morning	117	6.9	98	1.7	
Evening	124	6.5	81	1.4	
Day 23	Morning	120	6.5	65	1.1	
Evening	122	6	42	1	
Day 24	Morning	121	5.8	26	0.7	
Evening	122	5.5	-	-	
Day 25	121	5.6	7	0.3	
Day 27	138	4.6	-	-	
Day 28	140	4.2	-	-	
Day 32 (on discharge)	142	4.2	14	0.5	
On follow-up	139	4	10	0.3	

Slow dehydration correction was administered over 72 hours, and electrolytes were monitored 12 hours a day. Renal functions showed gradual improvement, but hyponatremia and hyperkalemia persisted even after sodium supplementation and administration of potassium-free fluids. There were episodes of intermittent asymptomatic hypoglycemia, mandating an increase of GIR up to 10 mg/kg/minute.

Considering the constellation of features like dark pigmentation of the skin, hyponatremia, hyperkalemia, hypoglycemia, and failure to thrive, a diagnosis of adrenal insufficiency was made. Additional hormonal levels are summarized in Table 2.

Table 2 Hormone assay

Investigation	Patient’s level	Normal range	Interpretation	
Adrenocorticotropic hormone	1,045 pg/mL	<60  pg/mL	High	
Aldosterone	4.47 ng/dL	20-790 ng/dL	Low	
17-Hydroxyprogesterone	1.19  ng/dL	<250 ng/dL	Low	
Cortisol	0.72  mcg/dL	2.8-23 mcg/dL	Low	

Ultrasound of the abdomen showed bilaterally enlarged adrenal glands and the presence of Müllerian structures. On day 25, the infant was started on a standard regimen of hydrocortisone at 20 mg/m2/day, fludrocortisone at 0.1 mg/day, and sodium supplementation at 3 mEq/kg/day. There was a gradual improvement toward normalization of sodium and potassium, as shown in Table 1. The baby became euglycemic and was able to consume full feeds.

Given multiple episodes of hypoglycemia, an MRI of the brain was done, which showed T2 fluid-attenuated inversion recovery hyperintensities in the occipital region with diffusion restriction, mostly due to hypoglycemic insult to the brain. A genetic study with targeted gene sequencing was done, which gave a final diagnosis of lipoid CAH (LCAH) due to a homozygous mutation of the steroidogenic acute regulatory protein (StAR) gene with autosomal recessive inheritance.

The baby was discharged by day 10 on continued oral hydrocortisone, fludrocortisone, and sodium supplements. The parents were explained genetic counseling before the next pregnancy. On follow-up, after two weeks of discharge, the baby was euglycemic with an adequate weight gain of 20 mg/kg/day and normal electrolytes, as depicted in Table 1.

Discussion

CLAH is an autosomal recessive disorder caused by a mutation in the StAR gene. The function of StAR is the transport of cholesterol from the outer membrane to the inner membrane of mitochondria so that it can be cleaved into pregnenolone [4]. As a result, further hormone biosynthesis does not occur in the adrenals, leading to a myriad of clinical manifestations. The symptomatology, age of onset, and severity of LCAH varied significantly in cases reported in the literature except for genital phenotype, which is similar in both sexes [5].

The deficiency of glucocorticoids manifests as hypoglycemia with low cortisol levels, as was seen in our case. The mineralocorticoid deficiency is depicted by low aldosterone levels with hyponatremia and hyperkalemia, which was refractory to general electrolyte correction measures in our case, like sodium supplementation and potassium-free fluid. Massive adrenal enlargement is classically seen in LCAH, but some cases have also reported normal or small adrenal gland size [6]. The external genital was of a normal female, and the ultrasound confirmed the presence of Müllerian structures, indicating the female gender. Gender assignment is crucial in CLAH, as neonates with XY karyotypes can have female external genitalia due to the absence of testosterone [7].

Generalized hyperpigmentation served as an important clue for diagnosis. Due to the absence of negative feedback by adrenal hormones, adrenocorticotropic hormone (ACTH) secretion remains unchecked from the anterior pituitary, which causes hyperpigmentation by complementing the increased activity of melanocyte-stimulating hormone [8].

In the most common form of CAH, 21-hydroxylase deficiency, 17-hydroxyprogesterone levels are high, but in our case, it was low, which was a differentiating point. Low levels of 17-hydroxyprogesterone are seen in lipoid adrenal hyperplasia, 17,20 lyase deficiency, and 17-alpha-hydroxylase enzyme deficiency [9].

Treatment for LCAH aims to correct the deficiency in cortisol and aldosterone secretion and suppress ACTH overproduction [10]. In our case, the baby responded very well clinically and biochemically to hydrocortisone and fludrocortisone. Lifelong replacement therapy is needed in such cases. LCAH, being an autosomal recessive disorder, has a 25% chance of recurrence; hence, appropriate antenatal counseling should be done in future pregnancies.

Conclusions

LCAH is an extremely rare form of CAH that can be missed in newborn screening due to low 17-hydroxyprogesterone levels. Generalized hyperpigmentation with hyponatremia and hyperkalemia should alert the clinician to look for adrenal insufficiency rather than providing routine symptomatic therapy. If undiagnosed, this disease if untreated can turn fatal as the child may go into an adrenal crisis. Thus, clinicians must be very vigilant as early diagnosis and hormonal replacement therapy can be lifesaving for such babies.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Aditi Rawat, Sagar Karotkar, Mahaveer Lakra, Ravi Reddy

Acquisition, analysis, or interpretation of data:  Aditi Rawat, Revatdhamma Meshram, Amar Taksande

Drafting of the manuscript:  Aditi Rawat, Sagar Karotkar, Mahaveer Lakra, Ravi Reddy

Critical review of the manuscript for important intellectual content:  Aditi Rawat, Revatdhamma Meshram, Amar Taksande
==== Refs
References

1 Lipoid congenital adrenal hyperplasia due to STAR mutations in a Caucasian patient Endocrinol Diabetes Metab Case Rep Kaur J Casas L Bose HS 150119 2016 2016 27047663
2 Lipoid congenital adrenal hyperplasia by steroidogenic acute regulatory protein (STAR) gene mutation in an Italian infant: an uncommon cause of adrenal insufficiency Ital J Pediatr Bizzarri C Pisaneschi E Mucciolo M Pedicelli S Galeazzi D Novelli A Cappa M 57 43 2017 28637490
3 A case of lipoid congenital adrenal hyperplasia presenting with cholestasis Iran J Pediatr Khodadad A Modaresi V Kiani MA Rabani A Pakseresht B 539 542 21 2011 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446141/#CIT0010 23056846
4 Lipoid congenital adrenal hyperplasia with a novel StAR gene mutation Clin Med Insights Endocrinol Diabetes Bakkar AA Alsaedi A Kamal NM 11795514231167059 16 2023 37255966
5 A case of congenital lipoid adrenal hyperplasia Int J Prev Med Hashemipour M Ghasemi M Hovsepian S 510 514 3 2012 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415193/ 22891154
6 Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia J Clin Endocrinol Metab Bose HS Sato S Aisenberg J Shalev SA Matsuo N Miller WL 3636 3639 85 2000 11061515
7 Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene J Clin Invest Fujieda K Tajima T Nakae J 1265 1271 99 1997 9077535
8 Hyperpigmentation and ACTH - an overview of literature Ro Med J Sandru F Dumitrascu MC Albu SE Carsote M Valea A 309 312 31 2019
9 Congenital lipoid adrenal hyperplasia in a Saudi infant Endocrinol Diabetes Metab Case Rep Subki SH Wadea Mohammed Hussain R Al-Agha AE 22 294 2022 2022
10 Congenital adrenal hyperplasia Pediatr Rev Fraga NR Minaeian N Kim MS 74 84 45 2024 38296783
